organization
Gavi, the Vaccine Alliance
Also known as Gavi, GAVI Alliance, The Vaccine Alliance
Gavi, the Vaccine Alliance, is an international public-private partnership created in 2000 to increase equitable and sustainable use of vaccines in lower-income countries.[1] It reports that more than 1.3 billion children were vaccinated through programmes it supported between 2000 and 2025.[2] At a June 2025 pledging summit it secured more than US$9 billion of an US$11.9 billion target for 2026–2030, and the United States said it would not contribute further.[3][4]
Key facts
Gavi, the Vaccine Alliance, was created in 2000. It is an international organisation that brings the public and private sectors together to increase equitable and sustainable use of vaccines.[1] Its founding partners are the World Health Organization, UNICEF, the World Bank and the Gates Foundation.[5] Gavi describes its mission as saving lives and protecting people’s health through wider vaccine use.[6] It is separate from CEPI, the Coalition for Epidemic Preparedness Innovations, which was founded in 2017 to advance vaccines and other countermeasures against epidemics and pandemics.[7] See also WHO, one of Gavi’s founding partners. For the wider picture, see the infectious disease crash course.
This page describes an organisation and its funding. It is not medical advice; talk to a clinician about your own or your child’s vaccinations.
What Gavi pays for
Gavi reports that more than 1.3 billion children were vaccinated through routine programmes it supported between 2000 and 2025, including more than 73 million in 2025.[2] It estimates that this vaccination averted more than 23 million future deaths over the same period, 2.2 million of them in 2025.[8] These are Gavi’s own modelled estimates, not counts.
Gavi also funds global stockpiles of vaccines against Ebola, cholera, meningococcal disease, mpox and yellow fever, so that countries can respond quickly to outbreaks.[9] In 2025, by its own figures, more than 35 million girls were fully immunised against HPV with its support.[10] Coverage gaps remain: Gavi reports that coverage of a third dose of diphtheria-tetanus-pertussis vaccine (DTP3) was 82% in Gavi-supported countries in 2025, against a global average of 85%.[11]
Gavi also reports on vaccine supply. It says the number of manufacturers supplying prequalified Gavi-supported vaccines grew from 5 in 2001 to 19 in 2025, nearly half of them in low- and middle-income countries.[12] Countries can buy Gavi-supported vaccines through UNICEF or the Pan American Health Organization’s Revolving Fund, or procure them themselves.[13]
Who is eligible, and how countries graduate
Eligibility depends on national income. In 2026 a country qualifies if its most recent gross national income per capita, using World Bank data, was US$2,300 or less.[14] When that threshold was raised for the 2026–2030 period, Angola and Timor-Leste, which had previously left Gavi support, became eligible again. That brought the number of eligible countries to 56.[15]
Countries pass through set phases. They start in initial self-financing, move to a preparatory transition phase, and then to an eight-year accelerated transition. After that they become fully self-financing and can no longer get new financial support from Gavi.[16] Gavi says 19 countries had transitioned to full self-financing, including India, Indonesia and Viet Nam; it gives that count as of 2022 on one page and as of 2025 on another.[17] Two formerly transitioned countries, Angola and Timor-Leste, have since regained eligibility under the 2026 threshold, as described above.[15]
Co-financing
Every country receiving Gavi vaccine support has to pay part of the cost. In the initial self-financing phase the government pays a flat US$0.20 per dose for most routine vaccines. In the preparatory transition phase its share rises by 15% a year.[18] Gavi reports that supported countries have paid US$2.2 billion in co-financing since 2008, including a record US$301 million in 2025.[19]
The 2026–2030 strategy
In June 2024 Gavi’s Board approved its strategy for 2026–2030, called Gavi 6.0. It has four goals: introduce and scale up vaccines, strengthen health systems to reach more children, make immunisation programmes more sustainable, and keep vaccine markets healthy.[20] Gavi says the strategy aims to help countries vaccinate more than 500 million more children and adolescents and save 8 to 9 million more lives, including 1.5 million through HPV vaccine.[21] It plans to offer vaccines against more than 20 diseases, including dengue, and expects a new tuberculosis vaccine to arrive before the period ends.[22]
Funding and the US withdrawal
Gavi raises money from donors for five-year strategic periods. At a summit in Brussels on 25 June 2025, co-hosted by the European Union, the Gates Foundation and Gavi, donors pledged more than US$9 billion towards a US$11.9 billion target for 2026–2030.[3] The Gates Foundation pledged US$1.6 billion, and Team Europe (the EU and its member states) pledged more than EUR 2 billion.[23]
The United States did not pledge. In a video shown at the summit, US Health Secretary Robert F. Kennedy Jr. said the United States would not contribute further to Gavi until it re-earned public trust.[4] He questioned the safety of the diphtheria, tetanus and pertussis vaccine that Gavi funds in lower-income countries. Gavi disputed this, saying its vaccine choices follow WHO expert recommendations and that the vaccine’s benefits outweigh its temporary side effects.[24] For the wider US vaccine policy context, see the US mRNA vaccine policy debate.
Another large global health funder is the Global Fund, a partnership against AIDS, tuberculosis and malaria that says it raises and invests more than US$4 billion a year in more than 100 countries.[25]
Read next
The Global Fund to Fight AIDS, Tuberculosis and Malaria
How the Global Fund finances HIV, TB and malaria programmes: its governance, country committees, results claims and the 2025 Eighth Replenishment.
Questions readers ask
What does Gavi do?
Gavi is a public-private partnership, created in 2000, that helps lower-income countries buy and deliver vaccines. Its founding partners are WHO, UNICEF, the World Bank and the Gates Foundation. It also funds global stockpiles of Ebola, cholera, meningococcal, mpox and yellow fever vaccines.[1][5][9]
Which countries can get Gavi support?
In 2026, countries whose most recent gross national income per capita was US$2,300 or less are eligible. Gavi counts 56 eligible countries after Angola and Timor-Leste regained eligibility.[14][15]
Do countries pay anything for Gavi-supported vaccines?
Yes. Every country receiving Gavi vaccine support must co-finance part of the cost, starting at a flat US$0.20 per dose for most routine vaccines and rising as national income grows. Gavi reports that countries contributed a record US$301 million in 2025.[18][19]
Sources
· 25 claims from 5 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
Gavi, the Vaccine Alliance, was created in 2000 as an international organisation bringing together the public and private sectors to increase equitable and sustainable use of vaccines. confirmedas of 2026-11-07
- Operating model · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [2]
Gavi reports that more than 1.3 billion children were vaccinated through Gavi-supported routine programmes between 2000 and 2025, including more than 73 million in 2025. confirmedas of 2026-10-31
- Facts and figures · Gavi, the Vaccine Alliance · Primary source · Headline stats (figure ">1.3 billion") (retrieved 2026-11-07)
- About our Alliance · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [3]
At a pledging summit in Brussels on 25 June 2025, co-hosted by the European Union, the Gates Foundation and Gavi, donors pledged more than US$9 billion towards Gavi's US$11.9 billion target for 2026–2030. confirmedas of 2025-06-26
- World leaders recommit to immunisation amid global funding shortfall · Gavi, the Vaccine Alliance · Primary source · 2025-06-25 (retrieved 2026-11-07)
- World leaders recommit to immunisation amid global funding shortfall · Gavi, the Vaccine Alliance · Primary source · 2025-06-25 (retrieved 2026-11-07)
- Gavi 'disappointed' as US ends vaccine support · The Standard (AFP) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- [4]
In a video shown at the June 2025 Brussels summit, US Health Secretary Robert F. Kennedy Jr. said the United States would not contribute further to Gavi until it re-earned public trust. confirmedas of 2025-06-26
- US pulls funding from global vaccines group, saying it has 'ignored the science' · Associated Press (via KSAT) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- US pulls funding from global vaccines group, saying it has 'ignored the science' · Associated Press (via KSAT) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- Gavi 'disappointed' as US ends vaccine support · The Standard (AFP) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- [5]
Gavi's founding partners are the World Health Organization, UNICEF, the World Bank and the Gates Foundation. confirmedas of 2026-11-07
- About our Alliance · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- US pulls funding from global vaccines group, saying it has 'ignored the science' · Associated Press (via KSAT) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- [6]
Gavi describes its mission as saving lives and protecting people's health by increasing equitable and sustainable use of vaccines. confirmedas of 2026-11-07
- About our Alliance · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [7]
CEPI, the Coalition for Epidemic Preparedness Innovations, was founded in 2017 to advance vaccines and other countermeasures against epidemics and pandemics. confirmedas of 2026-02-01
- CEPI 3.0 Strategy (2027-2031) · CEPI · Primary source (retrieved 2026-10-10)
- [8]
Gavi estimates that the vaccination it supported averted more than 23 million future deaths between 2000 and 2025, including 2.2 million in 2025. confirmedas of 2026-10-31
- Facts and figures · Gavi, the Vaccine Alliance · Primary source · Headline stats (figure ">23 million") (retrieved 2026-11-07)
- About our Alliance · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [9]
Gavi funds global vaccine stockpiles for Ebola, cholera, meningococcal disease, mpox and yellow fever. confirmedas of 2026-11-07
- About our Alliance · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [10]
Gavi reports that more than 35 million girls were fully immunised against HPV with its support in 2025. confirmedas of 2026-10-31
- Facts and figures · Gavi, the Vaccine Alliance · Primary source · Mission goal section (figure ">35 million") (retrieved 2026-11-07)
- [11]
Gavi reports that DTP3 vaccination coverage in Gavi-supported countries reached 82% in 2025, compared with a global average of 85%. confirmedas of 2026-10-31
- Facts and figures · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [12]
Gavi says the number of manufacturers supplying prequalified Gavi-supported vaccines grew from 5 in 2001 to 19 in 2025, nearly half of them based in low- and middle-income countries. confirmedas of 2026-11-07
- About our Alliance · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [13]
Countries receiving Gavi vaccine support can buy vaccines through UNICEF or the Pan American Health Organization's Revolving Fund, or procure them themselves under Gavi's self-procurement policy. confirmedas of 2026-11-07
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [14]
For 2026, countries are eligible for Gavi support if their most recent gross national income per capita, using World Bank data, was US$2,300 or less. confirmedas of 2026-11-07
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [15]
Gavi raised its eligibility threshold to US$2,300 GNI per capita at the start of its 2026–2030 period, and two formerly transitioned countries, Angola and Timor-Leste, regained eligibility, bringing the number of Gavi-eligible countries to 56. confirmedas of 2026-11-07
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [16]
Gavi-eligible countries move through an initial self-financing phase, a preparatory transition phase and an eight-year accelerated transition phase, after which they become fully self-financing and can no longer access new Gavi financial support. confirmedas of 2026-11-07
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [17]
Gavi says 19 countries had transitioned out of its support to fully self-financing, including India, Indonesia and Viet Nam; its eligibility page gives that count as of 2022 and its about page as of 2025. confirmedas of 2026-11-07
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Eligibility · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- About our Alliance · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [18]
All countries receiving Gavi vaccine support must co-finance part of the cost; in the initial self-financing phase the contribution is a flat US$0.20 per dose for most routine vaccines, and in the preparatory transition phase it rises by 15% a year. confirmedas of 2026-11-07
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [19]
Gavi reports that supported countries have contributed US$2.2 billion in co-financing since 2008, including a record US$301 million in 2025. confirmedas of 2026-10-31
- Facts and figures · Gavi, the Vaccine Alliance · Primary source · Headline stats (figure "US$ 2.2 billion") (retrieved 2026-11-07)
- [20]
In June 2024 Gavi's Board approved its 2026–2030 strategy, Gavi 6.0, which has four goals - introducing and scaling up vaccines, strengthening health systems to increase equity, improving the sustainability of immunisation programmes, and ensuring healthy vaccine markets. confirmedas of 2026-11-07
- Phase 6 (2026-2030) · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Phase 6 (2026-2030) · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [21]
Gavi says its 2026–2030 strategy aims to help countries vaccinate more than 500 million more children and adolescents and save 8 to 9 million more lives, including 1.5 million through HPV vaccine. confirmedas of 2026-11-07
- Phase 6 (2026-2030) · Gavi, the Vaccine Alliance · Primary source · Goal 1: Introduce and scale up vaccines (figure: more than 500 million) (retrieved 2026-11-07)
- [22]
Under its 2026–2030 strategy Gavi plans to provide access to vaccines against more than 20 diseases, including dengue, and expects a new tuberculosis vaccine by the end of the period. confirmedas of 2026-11-07
- Phase 6 (2026-2030) · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [23]
At the June 2025 summit the Gates Foundation pledged US$1.6 billion to Gavi, and Team Europe (the EU and its member states) pledged more than EUR 2 billion. confirmedas of 2025-06-26
- World leaders recommit to immunisation amid global funding shortfall · Gavi, the Vaccine Alliance · Primary source · 2025-06-25 (retrieved 2026-11-07)
- World leaders recommit to immunisation amid global funding shortfall · Gavi, the Vaccine Alliance · Primary source · 2025-06-25 (retrieved 2026-11-07)
- Gavi 'disappointed' as US ends vaccine support · The Standard (AFP) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- [24]
In the video Kennedy questioned the safety of the diphtheria, tetanus and pertussis vaccine Gavi funds in lower-income countries; Gavi disputed this, saying its vaccine decisions follow WHO expert recommendations and that the vaccine's benefits outweigh its temporary side effects. confirmedas of 2025-06-26
- US pulls funding from global vaccines group, saying it has 'ignored the science' · Associated Press (via KSAT) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- US pulls funding from global vaccines group, saying it has 'ignored the science' · Associated Press (via KSAT) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- Gavi 'disappointed' as US ends vaccine support · The Standard (AFP) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- Gavi 'disappointed' as US ends vaccine support · The Standard (AFP) · Secondary source · 2025-06-26 (retrieved 2026-11-07)
- [25]
The Global Fund, a partnership to defeat AIDS, TB and malaria, says it raises and invests more than US$4 billion a year in more than 100 of the hardest-hit countries, and is the largest multilateral funder of global health grants in low- and middle-income countries, having disbursed more than US$73 billion since 2002. confirmedas of 2026-11-07
- About the Global Fund · The Global Fund · Primary source (retrieved 2026-11-07)
- About the Global Fund · The Global Fund · Primary source (retrieved 2026-11-07)
- About the Global Fund · The Global Fund · Primary source (retrieved 2026-11-07)
Revision history (2)
- Clarified that Gavi's count of 19 transitioned countries predates Angola and Timor-Leste regaining eligibility.
- Page created.
Created Nov 8, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 7, 2027.
Cite this page
"Gavi, the Vaccine Alliance." ContentLora, updated Nov 14, 2026. https://contentlora.com/wiki/gavi
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.